Laborie Medical Technologies takes the lead in diagnosing GERD with alpHaONE System
GERD, or gastroesophageal reflux disease, affects millions of people worldwide. Its diagnosis can be difficult, as current methods include invasive endoscopic exams and X-rays. But Laborie Medical Technologies is changing the game with their alpHaONE system—a wireless device that can be implanted in the esophagus and collect data for up to four days.
The alpHaONE system works by placing a small sensor capsule on the esophageal wall, a short distance from the stomach, and recording changes in pH levels over time. This data is then transmitted to a handheld device that logs the information and allows the user to document their meals, time spent lying down, and feelings of heartburn, coughs, or deep belches.
One of the standout features of the alpHaONE system is its ease of use. Patients can carry the handheld device with them wherever they go, making it easy to track their symptoms and lifestyle habits. Laborie also offers a virtual instruction program to help patients better understand how to use the device and interpret the data.
The New Hampshire-based company estimates that about 1 in 5 people in the U.S. may suffer from GERD. With the alpHaONE system, these patients can now receive a more accurate diagnosis and better manage their condition.
Laborie is a global medical technology company specializing in Gastroenterology, Urology & Urogynecology, and Obstetrics, Gynecology & Neonatal. Through the development and manufacture of high quality, high impact diagnostic and therapeutic products, Laborie consistently contributes to the improvement of patient outcomes.
The alpHaONE system is just one example of the many exciting developments happening in the world of medical research and development. As technology continues to advance, we can expect to see even more innovative solutions that will improve patient care and outcomes.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
